Auris Medical Holding Ltd
EARS
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.21M
Close$
$6.92
127.1% upside
Current Fair Value
127.1% upsideUndervalued by 127.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.21 Million |
|---|---|
| Enterprise Value | $3.70 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $- |
| Beta | 1.4 |
| Outstanding Shares | - |
Return
| Return on Equity | -245.16% |
|---|---|
| Return on Assets | -205.79% |
| Return on Invested Capital | -38.37% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0.06 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -10.46 |
| Enterprise Value to EBIT | -1.42 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Auris Medical Holding Ltd
132,200 employees
CEO: Thomas Meyer Auris Medical is a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders. The Company is focused on the development of intranasal be...